Rahman, R.; Zayad, A.; Awadallah, C.; Wang, B.; Wu, J.; Khaliq, A.; Mewawalla, P.; Atrash, S.; Mudaranthakam, D.P.; McGuirk, J.;
et al. Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients. Curr. Oncol. 2026, 33, 246.
https://doi.org/10.3390/curroncol33050246
AMA Style
Rahman R, Zayad A, Awadallah C, Wang B, Wu J, Khaliq A, Mewawalla P, Atrash S, Mudaranthakam DP, McGuirk J,
et al. Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients. Current Oncology. 2026; 33(5):246.
https://doi.org/10.3390/curroncol33050246
Chicago/Turabian Style
Rahman, Raeef, Anas Zayad, Carmel Awadallah, Beining Wang, Jianzheng Wu, Aroog Khaliq, Prerna Mewawalla, Shebli Atrash, Dinesh Pal Mudaranthakam, Joseph McGuirk,
and et al. 2026. "Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients" Current Oncology 33, no. 5: 246.
https://doi.org/10.3390/curroncol33050246
APA Style
Rahman, R., Zayad, A., Awadallah, C., Wang, B., Wu, J., Khaliq, A., Mewawalla, P., Atrash, S., Mudaranthakam, D. P., McGuirk, J., Mahmoudjafari, Z., Mushtaq, M. U., Abdallah, A.-O., Ahmed, N., Snyder, J., Mazloom, A., Alkharabsheh, O., & Shah, M. R.
(2026). Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients. Current Oncology, 33(5), 246.
https://doi.org/10.3390/curroncol33050246
